Atriva is a privately funded company. Investors include:

  • Meneldor, an investment fund focused on early stage biotech and pharma companies that (re)develop (New) Biological or Chemical Molecular Entities, that have outstanding technology with strong IP, address significant unmet medical needs and attractive markets.
  • High-Tech Gründerfonds (HTGF), a Germany-based seed investor for innovative technologies and business models, successful in supporting the best founders whose ideas can revolutionize entire industries and improve people’s lives.
  • Private investors and Atriva management and founders


Business Development

Atriva works with leading academic institutions and research centers in its development activities.

The Company welcomes new development partnerships and collaborations with both industry and academia.

Please contact us with financing or BD inquiries.




Atriva Therapeutics GmbH
Eisenbahnstr. 1, 72072 Tübingen

+49 (0)7071 8597673


In order to be able to design our website in the best possible way and to continuously improve it, we are using cookies. By continuing to use our website, you permit the use of cookies. More information can be found in our data protection rules.